Novel aspects of the roles of Rac1 GTPase in the cardiovascular system

Current Opinion in Pharmacology

Volumn 10, Issue 2, 2010, Pages 116-121

  Sawada, Naoki ^a   Li, Yuxin ^b   Liao, James K ^b  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINO 6 [2 [[4 (DIETHYLAMINO) 1 METHYLBUTYL]AMINO] 6 METHYL 4 PYRIMIDINYL] 2 METHYLQUINOLINE; ACTIN; ANGIOTENSIN II; ARTEMIN; BONE MORPHOGENETIC PROTEIN 6; ENDOTHELIAL NITRIC OXIDE SYNTHASE; FIBROBLAST GROWTH FACTOR 5; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NITRIC OXIDE; RAC1 PROTEIN; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; STAT3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ANGIOGENESIS; BLOOD VESSEL PERMEABILITY; CARDIOVASCULAR DISEASE; CELL MOTILITY; CELL PROLIFERATION; CELL SHAPE; CELL SPECIFICITY; CELL TYPE; CEREBROVASCULAR ACCIDENT; CYTOLOGY; DISEASE MODEL; ENDOTHELIUM CELL; ENZYME ACTIVITY; GENE DELETION; GENE TARGETING; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART MUSCLE CELL; HEART VENTRICLE HYPERTROPHY; IN VITRO STUDY; MEDICAL RESEARCH; MOLECULAR MECHANICS; MUTAGENESIS; NEUROPROTECTION; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN FUNCTION; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; VASCULAR ENDOTHELIUM; VASCULAR SMOOTH MUSCLE;

ANIMALS; CAPILLARY PERMEABILITY; CARDIOVASCULAR SYSTEM; ENDOTHELIUM, VASCULAR; HEART DISEASES; HUMANS; MODELS, BIOLOGICAL; NEOVASCULARIZATION, PHYSIOLOGIC; RAC1 GTP-BINDING PROTEIN; SIGNAL TRANSDUCTION; STROKE;

EID: 77949760277     PISSN: 14714892     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.coph.2009.11.004     Document Type: Review

References (45)

1. Lezoualc'h F., Metrich M., Hmitou I., Duquesnes N., Morel E. Small GTP-binding proteins and their regulators in cardiac hypertrophy. J Mol Cell Cardiol 2008, 44:623-632.
2. Hordijk P.L. Regulation of NADPH oxidases: the role of Rac proteins. Circ Res 2006, 98:453-462.
3. Tzima E. Role of small GTPases in endothelial cytoskeletal dynamics and the shear stress response. Circ Res 2006, 98:176-185.
4. Gregg D., Rauscher F.M., Goldschmidt-Clermont P.J. Rac regulates cardiovascular superoxide through diverse molecular interactions: more than a binary GTP switch. Am J Physiol Cell Physiol 2003, 285:C723-C734.
5. Bosco E.E., Mulloy J.C., Zheng Y. Rac1 GTPase: a " Rac" of all trades. Cell Mol Life Sci 2009, 66:370-374.
6. Satoh M., Ogita H., Takeshita K., Mukai Y., Kwiatkowski D.J., Liao J.K. Requirement of Rac1 in the development of cardiac hypertrophy. Proc Natl Acad Sci U S A 2006, 103:7432-7437.
7. Tan W., Palmby T.R., Gavard J., Amornphimoltham P., Zheng Y., Gutkind J.S. An essential role for Rac1 in endothelial cell function and vascular development. FASEB J 2008, 22:1829-1838.
8. Sawada N., Salomone S., Kim H.H., Kwiatkowski D.J., Liao J.K. Regulation of endothelial nitric oxide synthase and postnatal angiogenesis by Rac1. Circ Res 2008, 103:360-368.
9. Sawada N., Kim H.H., Moskowitz M.A., Liao J.K. Rac1 is a critical mediator of endothelium-derived neurotrophic activity. Sci Signal 2009, 2:ra10.
10. Shen E., Li Y., Shan L., Zhu H., Feng Q., Arnold J.M., Peng T. Rac1 is required for cardiomyocyte apoptosis during hyperglycemia. Diabetes 2009, 58:2386-2395.
11. Nassar N., Cancelas J., Zheng J., Williams D.A., Zheng Y. Structure-function based design of small molecule inhibitors targeting Rho family GTPases. Curr Top Med Chem 2006, 6:1109-1116.
12. Hingtgen S.D., Tian X., Yang J., Dunlay S.M., Peek A.S., Wu Y., Sharma R.V., Engelhardt J.F., Davisson R.L. Nox2-containing NADPH oxidase and Akt activation play a key role in angiotensin II-induced cardiomyocyte hypertrophy. Physiol Genomics 2006, 26:180-191.
13. Custodis F., Eberl M., Kilter H., Bohm M., Laufs U. Association of RhoGDIalpha with Rac1 GTPase mediates free radical production during myocardial hypertrophy. Cardiovasc Res 2006, 71:342-351.
14. Yoshida M., Shiojima I., Ikeda H., Komuro I. Chronic doxorubicin cardiotoxicity is mediated by oxidative DNA damage-ATM-p53-apoptosis pathway and attenuated by pitavastatin through the inhibition of Rac1 activity. J Mol Cell Cardiol 2009, 47:698-705.
15. Zhu H., Shan L., Peng T. Rac1 mediates sex difference in cardiac tumor necrosis factor-alpha expression via NADPH oxidase-ERK1/2/p38 MAPK pathway in endotoxemia. J Mol Cell Cardiol 2009, 47:264-274.
16. Dudley S.C., Hoch N.E., McCann L.A., Honeycutt C., Diamandopoulos L., Fukai T., Harrison D.G., Dikalov S.I., Langberg J. Atrial fibrillation increases production of superoxide by the left atrium and left atrial appendage: role of the NADPH and xanthine oxidases. Circulation 2005, 112:1266-1273.
17. Adam O., Frost G., Custodis F., Sussman M.A., Schafers H.J., Bohm M., Laufs U. Role of Rac1 GTPase activation in atrial fibrillation. J Am Coll Cardiol 2007, 50:359-367.
18. Tsai C.T., Lai L.P., Kuo K.T., Hwang J.J., Hsieh C.S., Hsu K.L., Tseng C.D., Tseng Y.Z., Chiang F.T., Lin J.L. Angiotensin II activates signal transducer and activators of transcription 3 via Rac1 in atrial myocytes and fibroblasts: implication for the therapeutic effect of statin in atrial structural remodeling. Circulation 2008, 117:344-355.
19. Simeone-Penney M.C., Severgnini M., Rozo L., Takahashi S., Cochran B.H., Simon A.R. PDGF-induced human airway smooth muscle cell proliferation requires STAT3 and the small GTPase Rac1. Am J Physiol Lung Cell Mol Physiol 2008, 294:L698-L704.
20. Selvakumar B., Hess D.T., Goldschmidt-Clermont P.J., Stamler J.S. Co-regulation of constitutive nitric oxide synthases and NADPH oxidase by the small GTPase Rac. FEBS Lett 2008, 582:2195-2202.
21. Kou R., Michel T. Epinephrine regulation of the endothelial nitric-oxide synthase: roles of RAC1 and beta3-adrenergic receptors in endothelial NO signaling. J Biol Chem 2007, 282:32719-32729.
22. Moldovan L., Mythreye K., Goldschmidt-Clermont P.J., Satterwhite L.L. Reactive oxygen species in vascular endothelial cell motility. Roles of NAD(P)H oxidase and Rac1. Cardiovasc Res 2006, 71:236-246.
23. Monaghan-Benson E., Burridge K. The regulation of vascular endothelial growth factor-induced microvascular permeability requires Rac and reactive oxygen species. J Biol Chem 2009, 284:25602-25611.
24. Baumer Y., Spindler V., Werthmann R.C., Bunemann M., Waschke J. Role of Rac 1 and cAMP in endothelial barrier stabilization and thrombin-induced barrier breakdown. J Cell Physiol 2009, 220:716-726.
25. Peng H, Wang C, Ye ZC, Chen YR, Zhang J, Chen ZJ, Yu XQ, Lou TQ: How increased VEGF induces glomerular hyperpermeability: a potential signaling pathway of Rac1 activation. Acta Diabetol. In press. doi:10.1007/s00592-009r-r0121-8.
26. Gavard J., Hou X., Qu Y., Masedunskas A., Martin D., Weigert R., Li X., Gutkind J.S. A role for a CXCR2/phosphatidylinositol 3-kinase gamma signaling axis in acute and chronic vascular permeability. Mol Cell Biol 2009, 29:2469-2480.
27. Knezevic I.I., Predescu S.A., Neamu R.F., Gorovoy M.S., Knezevic N.M., Easington C., Malik A.B., Predescu D.N. Tiam1 and Rac1 are required for platelet-activating factor-induced endothelial junctional disassembly and increase in vascular permeability. J Biol Chem 2009, 284:5381-5394.
28. Seebach J., Donnert G., Kronstein R., Werth S., Wojciak-Stothard B., Falzarano D., Mrowietz C., Hell S.W., Schnittler H.J. Regulation of endothelial barrier function during flow-induced conversion to an arterial phenotype. Cardiovasc Res 2007, 75:596-607.
29. Birukova A.A., Zagranichnaya T., Fu P., Alekseeva E., Chen W., Jacobson J.R., Birukov K.G. Prostaglandins PGE(2) and PGI(2) promote endothelial barrier enhancement via PKA- and Epac1/Rap1-dependent Rac activation. Exp Cell Res 2007, 313:2504-2520.
30. Wojciak-Stothard B., Tsang L.Y., Paleolog E., Hall S.M., Haworth S.G. Rac1 and RhoA as regulators of endothelial phenotype and barrier function in hypoxia-induced neonatal pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol 2006, 290:L1173-L1182.
31. Liu W.F., Nelson C.M., Tan J.L., Chen C.S. Cadherins, RhoA, and Rac1 are differentially required for stretch-mediated proliferation in endothelial versus smooth muscle cells. Circ Res 2007, 101:e44-e52.
32. Diebold I., Djordjevic T., Petry A., Hatzelmann A., Tenor H., Hess J., Gorlach A. Phosphodiesterase 2 mediates redox-sensitive endothelial cell proliferation and angiogenesis by thrombin via Rac1 and NADPH oxidase 2. Circ Res 2009, 104:1169-1177.
33. Heller R., Chang Q., Ehrlich G., Hsieh S.N., Schoenwaelder S.M., Kuhlencordt P.J., Preissner K.T., Hirsch E., Wetzker R. Overlapping and distinct roles for PI3Kbeta and gamma isoforms in S1P-induced migration of human and mouse endothelial cells. Cardiovasc Res 2008, 80:96-105.
34. Deudero J.J., Caramelo C., Castellanos M.C., Neria F., Fernandez-Sanchez R., Calabia O., Penate S., Gonzalez-Pacheco F.R. Induction of hypoxia-inducible factor 1alpha gene expression by vascular endothelial growth factor. J Biol Chem 2008, 283:11435-11444.
35. Garrett T.A., Van Buul J.D., Burridge K. VEGF-induced Rac1 activation in endothelial cells is regulated by the guanine nucleotide exchange factor Vav2. Exp Cell Res 2007, 313:3285-3297.
36. Hunter S.G., Zhuang G., Brantley-Sieders D., Swat W., Cowan C.W., Chen J. Essential role of Vav family guanine nucleotide exchange factors in EphA receptor-mediated angiogenesis. Mol Cell Biol 2006, 26:4830-4842.
37. Koh W., Mahan R.D., Davis G.E. Cdc42- and Rac1-mediated endothelial lumen formation requires Pak2, Pak4 and Par3, and PKC-dependent signaling. J Cell Sci 2008, 121:989-1001.
38. Varon C., Basoni C., Reuzeau E., Moreau V., Kramer I.J., Genot E. TGFbeta1-induced aortic endothelial morphogenesis requires signaling by small GTPases Rac1 and RhoA. Exp Cell Res 2006, 312:3604-3619.
39. Kamei M., Saunders W.B., Bayless K.J., Dye L., Davis G.E., Weinstein B.M. Endothelial tubes assemble from intracellular vacuoles in vivo. Nature 2006, 442:453-456.
40. Ushio-Fukai M., Urao N. Novel role of NADPH oxidase in angiogenesis and stem/progenitor cell function. Antioxid Redox Signal 2009, 11:2517-2533.
41. Rao G.K., Bender J.R. Rac, PAK, and eNOS ACTion. Circ Res 2008, 103:328-330.
42. Ushio-Fukai M. Localizing NADPH oxidase-derived ROS. Sci STKE 2006, 2006:re8.
43. Shibata S., Nagase M., Yoshida S., Kawarazaki W., Kurihara H., Tanaka H., Miyoshi J., Takai Y., Fujita T. Modification of mineralocorticoid receptor function by Rac1 GTPase: implication in proteinuric kidney disease. Nat Med 2008, 14:1370-1376.
44. Tauseef M., Kini V., Knezevic N., Brannan M., Ramchandaran R., Fyrst H., Saba J., Vogel S.M., Malik A.B., Mehta D. Activation of sphingosine kinase-1 reverses the increase in lung vascular permeability through sphingosine-1-phosphate receptor signaling in endothelial cells. Circ Res 2008, 103:1164-1172.
45. Singleton P.A., Chatchavalvanich S., Fu P., Xing J., Birukova A.A., Fortune J.A., Klibanov A.M., Garcia J.G., Birukov K.G. Akt-mediated transactivation of the S1P1 receptor in caveolin-enriched microdomains regulates endothelial barrier enhancement by oxidized phospholipids. Circ Res 2009, 104:978-986.